These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32471179)

  • 21. Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization.
    Filipska I; Winiarska A; Knysak M; Stompór T
    Toxins (Basel); 2021 Apr; 13(4):. PubMed ID: 33920096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin K status and physical decline in older adults-The Longitudinal Aging Study Amsterdam.
    van Ballegooijen AJ; van Putten SR; Visser M; Beulens JW; Hoogendijk EO
    Maturitas; 2018 Jul; 113():73-79. PubMed ID: 29903651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma Desphospho-Uncarboxylated Matrix Gla Protein as a Marker of Kidney Damage and Cardiovascular Risk in Advanced Stage of Chronic Kidney Disease.
    Kurnatowska I; Grzelak P; Masajtis-Zagajewska A; Kaczmarska M; Stefańczyk L; Vermeer C; Maresz K; Nowicki M
    Kidney Blood Press Res; 2016; 41(3):231-9. PubMed ID: 27100101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Association of Low Vitamin K Status with Mortality in a Cohort of 138 Hospitalized Patients with COVID-19.
    Linneberg A; Kampmann FB; Israelsen SB; Andersen LR; Jørgensen HL; Sandholt H; Jørgensen NR; Thysen SM; Benfield T
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34207745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case report of sevelamer-associated recto-sigmoid ulcers.
    Tieu C; Moreira RK; Song LM; Majumder S; Papadakis KA; Hogan MC
    BMC Gastroenterol; 2016 Feb; 16():20. PubMed ID: 26911806
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
    Prajapati VA; Galani VJ; Shah PR
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):530-8. PubMed ID: 24821148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
    Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Thamratnopkoon S; Susantitaphong P; Tumkosit M; Katavetin P; Tiranathanagul K; Praditpornsilpa K; Eiam-Ong S
    Nephron; 2017; 135(3):167-172. PubMed ID: 27951533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimising the treatment of hyperphosphatemia and vascular calcification in chronic kidney disease.
    Cozzolino M; Brancaccio D
    Expert Opin Emerg Drugs; 2007 Sep; 12(3):341-3. PubMed ID: 17874964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
    Patel L; Bernard LM; Elder GJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional vitamin K insufficiency, vascular calcification and mortality in advanced chronic kidney disease: A cohort study.
    Dai L; Li L; Erlandsson H; Jaminon AMG; Qureshi AR; Ripsweden J; Brismar TB; Witasp A; Heimbürger O; Jørgensen HS; Barany P; Lindholm B; Evenepoel P; Schurgers LJ; Stenvinkel P
    PLoS One; 2021; 16(2):e0247623. PubMed ID: 33626087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.
    Ruggiero B; Trillini M; Tartaglione L; Rotondi S; Perticucci E; Tripepi R; Aparicio C; Lecchi V; Perna A; Peraro F; Villa D; Ferrari S; Cannata A; Mazzaferro S; Mallamaci F; Zoccali C; Bellasi A; Cozzolino M; Remuzzi G; Ruggenenti P; Kohan DE;
    Am J Kidney Dis; 2019 Sep; 74(3):338-350. PubMed ID: 31027883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenylacetylglutamine and trimethylamine N-oxide: Two uremic players, different actions.
    Hobson S; Qureshi AR; Ripswedan J; Wennberg L; de Loor H; Ebert T; Söderberg M; Evenepoel P; Stenvinkel P; Kublickiene K
    Eur J Clin Invest; 2023 Dec; 53(12):e14074. PubMed ID: 37548021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma p-cresol lowering effect of sevelamer in peritoneal dialysis patients: evidence from a Cross-Sectional Observational Study.
    Guida B; Cataldi M; Riccio E; Grumetto L; Pota A; Borrelli S; Memoli A; Barbato F; Argentino G; Salerno G; Memoli B
    PLoS One; 2013; 8(8):e73558. PubMed ID: 24015307
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K2 supplementation and arterial stiffness among renal transplant recipients-a single-arm, single-center clinical trial.
    Mansour AG; Hariri E; Daaboul Y; Korjian S; El Alam A; Protogerou AD; Kilany H; Karam A; Stephan A; Bahous SA
    J Am Soc Hypertens; 2017 Sep; 11(9):589-597. PubMed ID: 28756183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered gut microbiota and gut-derived p-cresyl sulfate serum levels in peritoneal dialysis patients.
    Bao M; Zhang P; Guo S; Zou J; Ji J; Ding X; Yu X
    Front Cell Infect Microbiol; 2022; 12():639624. PubMed ID: 36237423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population.
    Wei FF; Thijs L; Zhang ZY; Jacobs L; Yang WY; Salvi E; Citterio L; Cauwenberghs N; Kuznetsova T; E A Drummen N; Hara A; Manunta P; Li Y; Verhamme P; Allegaert K; Cusi D; Vermeer C; Staessen JA
    Nephrol Dial Transplant; 2018 Mar; 33(3):514-522. PubMed ID: 28340119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gut-kidney axis.
    Evenepoel P; Poesen R; Meijers B
    Pediatr Nephrol; 2017 Nov; 32(11):2005-2014. PubMed ID: 27848096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study.
    Riphagen IJ; Keyzer CA; Drummen NEA; de Borst MH; Beulens JWJ; Gansevoort RT; Geleijnse JM; Muskiet FAJ; Navis G; Visser ST; Vermeer C; Kema IP; Bakker SJL
    Nutrients; 2017 Dec; 9(12):. PubMed ID: 29292751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Causes of Vitamin K Deficiency in Patients on Haemodialysis.
    Wikstrøm S; Aagaard Lentz K; Hansen D; Melholt Rasmussen L; Jakobsen J; Post Hansen H; Andersen JR
    Nutrients; 2020 Aug; 12(9):. PubMed ID: 32825243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.